Common genetic and environmental effects on lipid phenotypes: The HERITAGE Family Study

Human Heredity

Volumn 59, Issue 1, 2005, Pages 34-40

  Feitosa, Mary F ^a   Rice, Treva ^a   Rankinen, Tuomo ^b   Almasy, Laura ^c   Leon, Arthur S ^d   Skinner, James S ^e   Wilmore, Jack H ^f   Bouchard, Claude ^b   Rao, D C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e INDIANA UNIVERSITY   (United States)

^f TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Coronary heart disease; Exercise; Genetics; Lipids; Lipoproteins; Pleiotropic effect; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CONTRACEPTIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DECOMPOSITION; ENDURANCE; ENVIRONMENTAL FACTOR; EUROPEAN AMERICAN; EXERCISE; FAMILY; FEMALE; GENETICS; HERITABILITY; HUMAN; PHENOTYPE; VARIANCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANALYSIS OF VARIANCE; CHOLESTEROL; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FAMILY HEALTH; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PHENOTYPE;

PIERINAE;

EID: 18644380596     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084735     Document Type: Article

References (28)

1. Lepor NE, Vogel RE: National Cholesterol Education Program Adult Treatment Panel III. Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III. Rev Cardiovasc Med 2001;2:160-165.
2. Walldius G, Jungner I: Apolipoprotein B and apolipoprotein A-I: Risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 2004;255:188-205.
3. Warnick GR: Measurement and clinical significance of high-density lipoprotein cholesterol subclasses; in Rifai M, Warnick GR, Dominiczak MH (eds): Handbook of Lipoprotein Testing. Washington, DC, AACC Press, 1997, pp 251-266.
4. Bakogianni MC, Kalofoutis CA, Skenderi KI, Kalofoutis AT: Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease. J Diabetes Complications 2001;15:265-269.
5. Rashid S, Barrett PH, Uffelman KD, Watanabe T, Adeli K, Lewis GF: Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol 2002;22:483-487.
6. Rashid S, Trinh DK, Uffelman KD, Cohn JS, Rader DJ, Lewis GF: Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-I. Circulation 2003;107:3066-3072.
7. Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
8. Ambrosch A, Muhlen I, Kopf D, Augustin W, Dierkes J, Konig W, Luley C, Lehnert H: LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care 1998;21:2077-2084.
9. Leon AS, Sanchez OA: Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001;33:S502-S515.
10. Sacks FM, Expert Group on HDL Cholesterol: The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am J Cardiol 2002;90:139-143.
11. Leon AS, Rice T, Mandel S, Després JP, Bergeron J, Gagnon J, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Blood lipid response to 20 weeks of supervised exercise in a large biracial population: The HERITAGE Family Study. Metabolism 2000;49:513-520.
12. Leon AS, Gaskill SE, Rice T, Bergeron J, Gagnon J, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Int J Sports Med 2002;23:1-9.
13. Couillard C, Després JP, Lamarche B, Bergeron J, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001;21:1226-1232.
14. Pérusse L, Rice T, Després JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol 1997;17:3263-3269.
15. Rice T, Després JP, Pérusse L, Hong Y, Province MA, Bergeron J, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC: Familial aggregation of blood lipid response to exercise training in the health, risk factors, exercise training, and genetics (HERITAGE) Family Study. Circulation 2002;105:1904-1908.
16. Bouchard C, Leon AS, Rao DC, Skinner JS, Wilmore JH, Gagnon J: The HERITAGE family study. Aims, design, and measurement protocol. Med Sci Sports Exerc 1995;27:721-729.
17. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966;15:45-52.
18. Burstein M, Samaille J: Sur un dosage rapide du cholestérol lie aux B-lipoprotéins du sérum. Clin Chim Acta 1960;5:609-610.
19. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-1223.
20. Després JP, Gagnon J, Bergeron J, et al: Plasma post-heparin lipase activities in the HERITAGE Family Study: the reproducibility, gender differences, and associations with lipoprotein levels. HEalth, Risk factors, exercise Training and GEnetics. Clin Biochem 1999;32:157-165.
21. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998 62:1198-1211.
22. Peacock JM, Arnett DK, Atwood LD, Myers RH, Coon H, Rich SS, Province MA, Heiss G: Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 2001;21:1823-1828.
23. Shearman AM, Ordovas JM, Cupples LA, Schaefer EJ, Harmon MD, Shao Y, Keen JD, DeStefano AL, Joost O, Wilson PW, Housman DE, Myers RH: Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: A genome-wide scan in the Framingham study. Hum Mol Genet 2000;9:1315-1320.
24. Hokanson JE, Langefeld CD, Mitchell BD, Lange LA, Goff DC Jr, Haffner SM, Saad MF, Rotter JI: Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: the IRAS Family Study. Hum Hered 2003;55:46-50.
25. Salonen JT, Salonen R, Seppanen K, Rauramaa R, Tuomilehto J: HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991;84:129-139.
26. Johansson J, Carlson LA, Landou C, Hamsten A: High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991;11:174-182.
27. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
28. Franceschini G: Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am J Cardiol 2001;88:9N-13N.